A rating of 75 puts LAVA Therapeutics NV (LVTX) near the top of the Biotechnology industry according to InvestorsObserver. LAVA Therapeutics NV's score of 75 means it scores higher than 75% of stocks in the industry. LAVA Therapeutics NV also received an overall rating of 57, putting it above 57% of all stocks. Biotechnology is ranked 67 out of the 148 industries.
LVTX has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on LVTX!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With LAVA Therapeutics NV Stock Today?
LAVA Therapeutics NV (LVTX) stock is trading at $1.68 as of 10:35 AM on Monday, Aug 28, a rise of $0.03, or 1.82% from the previous closing price of $1.65. The stock has traded between $1.68 and $1.73 so far today. Volume today is low. So far 3,221 shares have traded compared to average volume of 33,782 shares.
Click Here to get the full Stock Report for LAVA Therapeutics NV stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
